Long-term Benefits and Innovations in S-ICD Therapy: Exploring the Impact of APPRAISE ATP & MODULAR ATP
Published: 23 October 2024
-
Views:
498
-
Likes:
7
-
Views:
498
-
Likes:
7
-
12m 53sPart 5 Discussion
-
1m 45sPart 6 Closing Remarks
-
5m 13sPart 1 Introduction Ulrika Birgersdotter-Green, Blandine Mondésert, Pier D Lambiase, Claudio Schuger, Lluis Mont
-
12m 12sPart 2 Shaping SCD Treatment: Insights on Long-term S-ICD Use Pier D Lambiase
-
18m 28sPart 3 APPRAISE-ATP: Exploring Clinical Insights in Anti-Tachycardia Pacing Claudio Schuger
Overview
This video series covers the latest data on transvenous and subcutaneous ICD devices, focusing on shared decision-making and their practical applications in preventing sudden cardiac death. Moderated by Dr Blandine Mondésert (Montreal Heart Institute and University of Montreal, CA) and Dr Ulrika Birgersdotter-Green (University of California San Diego, US), this webinar delves into the long-term benefits and innovations in Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) therapy.
Viewers will gain insights into S-ICD and leadless pacing, alongside an analysis of Anti-Tachycardia Pacing (ATP) studies, including APPRAISE-ATP and MODULAR-ATP, to enhance treatment strategies and optimise patient outcomes in cardiovascular care.
Learning Objectives
- Understand the latest data on transvenous and entirely subcutaneous implantable cardioverter defibrillator (S-ICD) devices including the practical implications this data has on shared decision making
- Evaluate long-term efficacy and applications of S-ICD and leadless pacing in sudden cardiac death prevention
- Understand the long-term use and outcomes of S-ICD therapy
- Assess the integration of leadless pacing and S-ICD therapy in the context of preventing sudden cardiac death
- Analyse clinical insights and data from anti-tachycardia pacing (ATP) studies for improved treatment strategies
- Explore the clinical insights and benefits of ATP as detailed in the APPRAISE-ATP study
- Examine the data from the MODULAR-ATP study to enhance understanding of ATP's role in sudden death prevention and its integration with other therapies
Target Audience
- Cardiologist - Non-invasive
- Cardiothoracic Surgeon
- Cardiovascular Scientist
- Electrophysiologist
- Healthcare Professional in training
- Heart Failure Specialist
- Interventional Cardiologist
- Nurse/Nurse Practitioner
- Paediatric Cardiologist
- Primary Care Physician
More from this programme
Part 1
Introduction
| 1 session | |
| Introduction | Watch now |
Part 2
Shaping SCD Treatment: Insights on Long-term S-ICD Use
Part 3
APPRAISE-ATP: Exploring Clinical Insights in Anti-Tachycardia Pacing
Part 4
Integrating Leadless Pacing and S-ICD Therapy in Sudden Death Prevention: Insights from MODULAR-ATP Data
Part 5
Discussion
| 1 session | |
| Discussion | Watch now |
Part 6
Closing Remarks
| 1 session | |
| Closing Remarks | Watch now |
Faculty Biographies
Lluis Mont
Prof Lluis Mont is Head of the Arrhythmia Section and Atrial Fibrillation unit in the Cardiovascular Clinic Institute, Hospital Clinic in Barcelona, Spain. His research includes AF, cardiac resynchronisation therapy and he has been involved in the Micra IDE study, as well as the Micra Post-Approval Registry. He gives Micra training in his hospital and also serves as proctor.
Comments